Prostate volume and growth in testosterone-substituted hypogonadal men are dependent on the CAG repeat polymorphism of the androgen receptor gene: A longitudinal pharmacogenetic study

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 5, 2003, Pages 2049-2054

  Zitzmann, Michael ^a   Depenbusch, Marion ^a   Gromoll, Jörg ^a   Nieschlag, Eberhard ^a  

^a INST OF REPRO MED OF THE UNIV   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; ANDROGEN; CHORIONIC GONADOTROPIN; CYTOSINE; GUANINE; SEX HORMONE; TESTOSTERONE; TESTOSTERONE ENANTATE; TESTOSTERONE UNDECANOATE;

ADULT; AGE DETERMINATION; AGED; ANALYSIS OF VARIANCE; ANTHROPOMETRIC PARAMETERS; ARTICLE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; COVARIANCE; GENETIC POLYMORPHISM; GROWTH RATE; HUMAN; HYPOGONADISM; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; NUCLEOTIDE REPEAT; OBSERVATION; ORGAN GROWTH; ORGAN SIZE; PHARMACOGENETICS; PREDICTION; PRIORITY JOURNAL; PROSTATE; RISK; STATISTICAL SIGNIFICANCE; SUBSTITUTION THERAPY; TRANSRECTAL ULTRASONOGRAPHY;

ADULT; AGED; AGING; CHORIONIC GONADOTROPIN; CROSS-SECTIONAL STUDIES; HUMANS; HYPOGONADISM; LONGITUDINAL STUDIES; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; ODDS RATIO; PHARMACOGENETICS; PROSTATE; RECEPTORS, ANDROGEN; TESTOSTERONE; TREATMENT OUTCOME;

EID: 0038707532     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-021947     Document Type: Article

References (42)

1. Frick J, Jungwirth A, Rovan E 1998 Androgens and the prostate. In: Nieschlag E, Behre HM, eds. Testosterone: action, deficiency, substitution, ed 2. Berlin, Heidelberg: Springer; 260-291
2. Jin B, Conway AJ, Handelsman DJ 2001 Effects of androgen deficiency and replacement on prostate zonal volumes. Clin Endocrinol (Oxf) 54:437-445
3. Ozata M, Bulur M, Beyhan Z, Sengul A, Saglam M, Turan M, Corakci A, Ali Gundogan M 1997 Effects of gonadotropin and testosterone treatments on prostate volume and serum prostate specific antigen levels in male hypogonadism. Endocr J 44:719-724
4. Snyder PJ, Peachey H, Berlin JA, Hannoush P, Haddad G, Dlewati A, Santanna J, Loh L, Lenrow DA, Holmes JH, Kapoor SC, Atkinson LE, Strom BL 2000 Effects of testosterone replacement in hypogonadal men. J Clin Endocrinol Metab 85:2670-2677
5. Behre HM, von Eckardstein S, Kliesch S, Nieschlag E 1999 Long-term substitution therapy of hypogonadal men with transscrotal testosterone over 7-10 years. Clin Endocrinol (Oxf) 50:629-635
6. Kamischke A, Behre HM, Weinbauer GF, Nieschlag E 1997 The cynomolgus monkey prostate under physiological and hypogonadal conditions: an ultrasonographic study. J Urol 157:2340-2344
7. Behre HM, Bohmeyer J, Nieschlag E 1994 Prostate volume in testosteronetreated and untreated hypogonadal men in comparison to age-matched normal controls. Clin Endocrinol (Oxf) 40:341-349
8. Platz E-A, Rimm E-B, Willett W-C, Kantoff P-W, Giovannucci E 2000 Racial variation in prostate cancer incidence and in hormonal system markers among male health professionals. J Natl Cancer Inst 92:2009-2017
9. Hsing AW, Gao YT, Wu G, Wang X, Deng J, Chen YL, Sesterhenn IA, Mostofi FK, Benichou J, Chang C 2000 Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China. Cancer Res 1518:5111-5116
10. Kuhlenbäumer G, Kress W, Ringelstein EB, Stögbauer F 2001 Thirty-seven CAG repeats in the androgen receptor gene in two healthy individuals. J Neurol 2481:23-26
11. Chamberlain NL, Driver ED, Miesfeld RL 1994 The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 11:3181-3186
12. Beilin J, Ball EM, Favaloro JM, Zajac JD 2000 Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: specificity in prostate and non-prostate cell lines. J Mol Endocrinol 25:85-96
13. La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH 1991 Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352:77-79
14. Kennedy WR, Alter M, Sung JH 1968 Progressive proximal spinal and bulbar muscular atrophy of late onset. Neurology 18:671-680
15. Zitzmann M, Brune M, Kommann B, Gromoll J, Junker R, Nieschlag E 2001 The CAG repeat polymorphism in the androgen receptor gene affects bone density and bone metabolism in healthy males. Clin Endocr 55:649-658
16. Zitzmann M, Brune M, Kommann B, von Eckardstein S, von Eckardstein A, Gromoll J, Nieschlag E 2001 The CAG repeat polymorphism in the AR gene affects high density lipoprotem cholesterol and arterial vasoreactivity. J Clin Endocrinol Metab 86:4867-4873
17. Zitzmann M, von Eckardstein A, Gromoll J, Nieschlag E 2003 The CAG repeat polymorphism in the androgen receptor gene modulates body fat mass and serum levels of leptin and insulin in men. Diabetologia 46:31-39
18. von Eckardstein S, Syska A, Gromoll J, Kamischke A, Simoni M, Nieschlag E 2001 Inverse correlation between sperm concentration and number of androgen receptor CAG repeats in normal men. J Clin Endocrinol Metab 86:2585-2590
19. Rajpert-De Meyts E, Leffers H, Petersen JH, Andersen AG, Carlsen E, Jorgensen N, Skakkebaek NE 2002 CAG repeat length in androgen-receptor gene and reproductive variables in fertile and infertile men. Lancet 359:44-46
20. Seidman SN, Araujo AB, Roose SP, McKinlay J-B 2001 Testosterone level, androgen receptor polymorphism, and depressive symptoms in middle-aged men. Biol Psychiatry 50:371-376
21. Ellis JA, Stebbing M, Harrap SB 2001 Polymorphism of the androgen receptor gene is associated with male pattern baldness. J Invest Dermatol 116:452-455
22. Comings DE, Chen C, Wu S, Muhleman D 1999 Association of the androgen receptor gene AR with ADHD and conduct disorder. Neuroreport 10:1589-1592
23. Giovannucci E, Stampfer MJ, Krithivas K, Brown M, Dahl D, Brufsky A, Talcott, J, Hennekens CH, Kantoff PW 1997 The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc Natl Acad Sci USA 94:3320-3323
24. Stanford JL, Just JJ, Gibbs M, Wicklund KG, Neal CL, Blumenstein BA, Ostrander EA 1997 Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk. Cancer Res 576:1194-1198
25. Beilin J, Harewood L, Frydenberg M, Mameghan H, Martyres RF, Farish SJ, Yue C, Deam DR, Byron KA, Zajac JD 2001 A case-control study of the androgen receptor gene CAG repeat polymorphism in Australian prostate carcinoma subjects. Cancer 92:941-949
26. Latil AG, Azzouzi R, Cancel GS, Guillaume EC, Cochan-Priollet B, Berthon PL, Cussenot O 2001 Prostate carcinoma risk and allelic variants of genes involved in androgen biosynthesis and metabolism pathways. Cancer 925:1130-1137
27. Giovannucci E, Platz EA, Stampfer MJ, Chan A, Krithivas K, Kawachi I, Willett WC, Kantoff PW 1999 The CAG repeat within the androgen receptor gene and benign prostatic hyperplasia. Urology 53:121-125
28. von Eckardstein S, Schmidt A, Kamischke A, Simoni M, Gromoll J, Nieschlag E 2002 CAG repeat length in the androgen receptor gene and gonadotrophin suppression influence the effectiveness of hormonal male contraception. Clin Endocrinol (Oxf) 57:647-655
29. Yu B, Handelsman DJ 2001 Pharmacogenetic polymorphisms of the AR and metabolism and susceptibility to hormone-induced azoospermia. J Clin Endocrinol Metab 86:4406-4411
30. World Health Organization, Nieschlag E, Wang C, Handelsman DJ, Swerdloff RS, Wu F, Einer-Jensen N, Waites G 1992 Guidelines for the use of androgens. Geneva: World Health Organization
31. Smith KW, Feldman HA, McKinlay JB 2000 Construction and field validation of a self-administered screener for testosterone deficiency (hypogonadism) in ageing men. Clin Endocrinol 53:703-711
32. Veldhuis JD, Urban RJ, Lizarralde G, Johnson ML, Iranmanesh A 1992 Attenuation of hiteinizing hormone secretory burst amplitude as a proximate basis for the hypoandrogenism of healthy aging in men. J Clin Endocrinol Metab 75:707-713
33. Dejager S, Bry-Gauillard H, Bruckert E, Eymard B, Salachas F, LeGuern E, Tardieu S, Chadarevian R, Giral P, Turpin G 2002 A comprehensive endocrine description of Kennedy's disease revealing androgen insensitivity linked to CAG repeat length. J Clin Endocrinol Metab 87:3893-3901
34. Behre HM, Nieschlag E 1998 Comparative pharmacokinetics of testosterone esters. In: Nieschlag E, Behre HM, eds. Testosterone: action, deficiency, substitution, ed 2. Berlin, New York: Springer-Verlag; 329-348
35. Price H, McNeal JE, Stamey TA 1990 Evolving patterns of tissue composition in benign prostatic hyperplasia as a function of specimen size. Hum Pathol 21:578-585
36. Yeh S, Miyamoto H, Shima H, Chang C 1998 From estrogen to androgen receptor: a new pathway for sex hormones in prostate. Proc Natl Acad Sci USA 9510:5527-5532
37. Irvine RA, Ma H, Yu MC, Ross RK, Stallcup MR, Coetzee GA 2002 Inhibition of p160-mediated coactivation with increasing androgen receptor polyglutamine length. Hum Mol Genet 9:267-274
38. Mitsumori K, Terai A, Oka H, Segawa T, Ogura K, Yoshida O, Ogawa O 1999 Androgen receptor CAG repeat length polymorphism in benign prostatic hyperplasia BPH: correlation with adenoma growth. Prostate 414:253-257
39. Shibata A, Stamey TA, McNeal JE, Cheng I, Peehl DM 2001 Genetic polymorphisms in the androgen receptor and type II 5 alpha-reductase genes in prostate enlargement. J Urol 1664:1560-1564
40. Bousema JT, Bussemakers MJ, van Houwelingen KP, Debruyne FM, Verbeek AL, de La Rosette JJ, Kiemeney LA 2000 Polymorphisms in the vitamin D receptor gene and the androgen receptor gene and the risk of benign prostatic hyperplasia. Eur J Urol 37:234-238
41. Zitzmann M, Brune M, Nieschlag E 2002 Vascular reactivity in hypogonadal men is reduced by androgen substitution. J Clin Endocrinol Metab 87:5030-5037
42. Zitzmann M, Brune M, Vieth V, Nieschlag E 2002 Monitoring bone density in hypogonadal men by quantitative phalangeal ultrasound. Bone 314-322